Table 1 Baseline characteristics of patients
From: Lubiprostone, a novel laxative, might improve hyperphosphatemia without water dilution
Number of enrolled patients (men/women) | 28 (14/14) |
Age, years | 69.4 ± 14.2 |
Duration of dialysis, years | 7.7 ± 9.1 |
Underlying disease of renal failure | Diabetic nephropathy, 11 patients |
Chronic glomerulonephritis, 3 patients | |
Nephrosclerosis, 5 patients | |
Autosomal dominant polycystic kidney disease, 1 patient | |
Primary hyperparathyroidism, 1 patient | |
Unknown, 7 patients | |
Concomitant laxative | 17 patients |
Stimulant laxative, 17 patients | |
Sugar laxative, 1 patient | |
Phosphate binder | 18 patients |
Calcium carbonate, 8 patients | |
Lanthanum carbonate, 12 patients | |
Bixalomer, 2 patients | |
Ferric citrate hydrate, 1 patient | |
Cinacalcet, 4 patients |